271 related articles for article (PubMed ID: 37427673)
1. ASPN Synergizes with HAPLN1 to Inhibit the Osteogenic Differentiation of Bone Marrow Mesenchymal Stromal Cells and Extracellular Matrix Mineralization of Osteoblasts.
Zhou G; Yan X; Chen Z; Zeng X; Wu F
Orthop Surg; 2023 Sep; 15(9):2423-2434. PubMed ID: 37427673
[TBL] [Abstract][Full Text] [Related]
2. Inokosterone activates the BMP2 to promote the osteogenic differentiation of bone marrow mesenchymal stem cells and improve bone loss in ovariectomized rats.
Chen Q; Yang Z; Sun X; Long R; Shen J; Wang Z
Biochem Biophys Res Commun; 2023 Nov; 682():349-358. PubMed ID: 37839103
[TBL] [Abstract][Full Text] [Related]
3. Foxf1 knockdown promotes BMSC osteogenesis in part by activating the Wnt/β-catenin signalling pathway and prevents ovariectomy-induced bone loss.
Shen G; Ren H; Shang Q; Zhao W; Zhang Z; Yu X; Tang K; Tang J; Yang Z; Liang D; Jiang X
EBioMedicine; 2020 Feb; 52():102626. PubMed ID: 31981979
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of ring finger protein 11 regulating Akt signaling pathway to promote osteogenic differentiation of bone marrow mesenchymal stem cells].
Deng W; Long T; Du Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2022 Jan; 36(1):102-110. PubMed ID: 35038807
[TBL] [Abstract][Full Text] [Related]
5. microRNA-25-3p suppresses osteogenic differentiation of BMSCs in patients with osteoporosis by targeting ITGB3.
Yu D; Li Z; Cao J; Shen F; Wei G
Acta Histochem; 2022 Aug; 124(6):151926. PubMed ID: 35777302
[TBL] [Abstract][Full Text] [Related]
6. Methyl-CpG-binding protein 2 promotes osteogenic differentiation of bone marrow mesenchymal stem cells through regulating forkhead box F1/Wnt/β-Catenin axis.
Ji W; Sun X
Bioengineered; 2022 Jan; 13(1):583-592. PubMed ID: 34967263
[TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicles from GPNMB-modified bone marrow mesenchymal stem cells attenuate bone loss in an ovariectomized rat model.
Huang B; Su Y; Shen E; Song M; Liu D; Qi H
Life Sci; 2021 May; 272():119208. PubMed ID: 33582177
[TBL] [Abstract][Full Text] [Related]
8. A novel link between melatonin and circ_0005753/PTBP1/TXNIP regulatory network in the modulation of osteogenic potential in mesenchymal stem cells.
Tu W; Zhu S; Li F; Xu C; Tu W; Chen Y
Chem Biol Drug Des; 2024 Jan; 103(1):e14380. PubMed ID: 37890873
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol alleviates osteoporosis through improving the osteogenic differentiation of bone marrow mesenchymal stem cells.
Chen XH; Shi ZG; Lin HB; Wu F; Zheng F; Wu CF; Huang MW
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6352-6359. PubMed ID: 31364143
[TBL] [Abstract][Full Text] [Related]
10. Silencing of miR-330-5p stimulates osteogenesis in bone marrow mesenchymal stem cells and inhibits bone loss in osteoporosis by activating Bgn-mediated BMP/Smad pathway.
Jin SL; Bai YM; Zhao BY; Wang QH; Zhang HS
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4095-4102. PubMed ID: 32374006
[TBL] [Abstract][Full Text] [Related]
11. [Role of M2 Macrophage Exosomes in Osteogenic Differentiation of Mouse Bone Marrow Mesenchymal Stem Cells under High-Glucose and High-Insulin].
Zhang C; Bao LR; Yang YT; Wang Z; Li Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):63-70. PubMed ID: 35048602
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MALAT1 inhibits osteogenic differentiation of mesenchymal stem cells in osteoporosis rats through MAPK signaling pathway.
Zheng S; Wang YB; Yang YL; Chen BP; Wang CX; Li RH; Huang D
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4609-4617. PubMed ID: 31210287
[TBL] [Abstract][Full Text] [Related]
13. The lncRNA H19/miR-541-3p/Wnt/β-catenin axis plays a vital role in melatonin-mediated osteogenic differentiation of bone marrow mesenchymal stem cells.
Han H; Tian T; Huang G; Li D; Yang S
Aging (Albany NY); 2021 Jul; 13(14):18257-18273. PubMed ID: 34311444
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA HCG18 inhibits the differentiation of human bone marrow-derived mesenchymal stem cells in osteoporosis by targeting miR-30a-5p/NOTCH1 axis.
Che M; Gong W; Zhao Y; Liu M
Mol Med; 2020 Nov; 26(1):106. PubMed ID: 33176682
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-449b-5p promotes the progression of osteoporosis by inhibiting osteogenic differentiation of BMSCs via targeting Satb2.
Li JY; Wei X; Sun Q; Zhao XQ; Zheng CY; Bai CX; Du J; Zhang Z; Zhu LG; Jia YS
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6394-6403. PubMed ID: 31378877
[TBL] [Abstract][Full Text] [Related]
16. Loss of N-acetylglucosaminyl transferase V is involved in the impaired osteogenic differentiation of bone marrow mesenchymal stem cells.
Liu XP; Li JQ; Li RY; Cao GL; Feng YB; Zhang W
Exp Anim; 2023 Aug; 72(3):413-424. PubMed ID: 37019682
[TBL] [Abstract][Full Text] [Related]
17. Hmga1-overexpressing lentivirus protects against osteoporosis by activating the Wnt/β-catenin pathway in the osteogenic differentiation of BMSCs.
Wu Z; Zhu J; Wen Y; Lei P; Xie J; Shi H; Wu R; Lou X; Hu Y
FASEB J; 2023 Sep; 37(9):e22987. PubMed ID: 37555233
[TBL] [Abstract][Full Text] [Related]
18. Melatonin promotes bone marrow mesenchymal stem cell osteogenic differentiation and prevents osteoporosis development through modulating circ_0003865 that sponges miR-3653-3p.
Wang X; Chen T; Deng Z; Gao W; Liang T; Qiu X; Gao B; Wu Z; Qiu J; Zhu Y; Chen Y; Liang Z; Zhou H; Xu C; Liang A; Su P; Peng Y; Huang D
Stem Cell Res Ther; 2021 Feb; 12(1):150. PubMed ID: 33632317
[TBL] [Abstract][Full Text] [Related]
19. Human umbilical cord mesenchymal stromal cells-derived extracellular vesicles exert potent bone protective effects by CLEC11A-mediated regulation of bone metabolism.
Hu Y; Zhang Y; Ni CY; Chen CY; Rao SS; Yin H; Huang J; Tan YJ; Wang ZX; Cao J; Liu ZZ; Xie PL; Wu B; Luo J; Xie H
Theranostics; 2020; 10(5):2293-2308. PubMed ID: 32089743
[TBL] [Abstract][Full Text] [Related]
20. Surfactin suppresses osteoclastogenesis via the NF-κB signaling pathway, promotes osteogenic differentiation in vitro, and inhibits oestrogen deficiency-induced bone loss in vivo.
Kuang Z; Yang X; Cao Z; Li Y; Hu J; Hong X; Li B; Wu C; Qi Q; Liu X; Dai M
Int Immunopharmacol; 2023 Apr; 117():109884. PubMed ID: 36805201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
